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1. Introduction
  Human brucellosis is the commonest bacterial zoonosis 
worldwide[1] with an indolent course quite prevalent in 
the developing countries including India. It is classified 
as a Class B Bioterrorist agent[2] and is one of the highly 
neglected tropical diseases. It masquerades multiple 
infectious and non infectious conditions causing a 
significant diagnostic dilemma[3]. Since India is endemic 
for tuberculosis, there is always an overlap in the clinical 
symptomatology and treatment.  Moreover, the surveillance 
of this organism is not practised regularly and hence the 
true incidence of the disease is not known. It is under 
diagnosed, underreported and is probably tip of the 
iceberg[3]. The exact burden of this problem is not known 
in India because of paucity of reports and the disease being 
misdiagnosed as other conditions. Moreover, there are 
hardly any studies in India, which have specifically looked 
at laboratory parameters and its clinical correlation.
2. Materials and methods
  This retrospective study was undertaken in Kasturba 
Medical College, an affiliate medical school of Manipal 
University, Karnataka, India. Kasturba Hospital in 
Manipal, India is a 1 560 bedded tertiary care university 
hospital in southern India. The medical records at Kasturba 
Hospital, Manipal, India were accessed and all consecutive 
cases from January 2006 to April 2010 with the diagnosis of 
human brucellosis as per the International Classification 
of Diseases codes were included in the study. Diagnosis of 
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brucellosis was made by culturing the sera/body fluids on 
standard BACTEC method[3] (or) testing the sera for brucella 
agglutinins using the standard agglutination test (SAT). 
A titer of 1:320 or more was considered as significant[4]. 
Standardised chart abstraction form was used to obtain 
baseline demographic data, predisposing factors, clinical 
features, laboratory data, treatment details and outcome. 
SPSS 16 was used for statistical analysis and Microsoft Excel 
for graphical representation.
3. Results
  Out of 68 patients, 46 (68%) were males and 22 (32%) 
females with age distribution in the range of 9 -75 years. 
Patients mainly presented with fever as the predominant 
symptom in 68 cases (100%). The other symptoms were 
myalgia (21, 31%), musculoskeletal symptoms (arthralgia, 
backache) (23, 34%), headache (16, 24%), gastrointestinal 
symptoms (nausea, vomiting, diarrhoea, constipation and 
pain abdomen (19, 28%) and altered sensorium (3, 4%). In 
the present study, 44 (64.7%) cases showed history of contact 
with unpasteurized dairy products or infected animals. Co-
morbidities and associations included HIV positivity (2, 
3%), Type 2 Diabetes mellitus (13, 19%), steroid therapy 
(3, 4%) and HBsAg positivity (8, 12%). On physical 
examination, cervical lymphadenopathy was shown in 10 
cases (15%), splenic enlargement in 4(6%), hepatomegaly 
in 6 (7%), hepatosplenomegaly in 19 (28%) and meningeal 
signs in 2(3%). The haematological abnormalities included 
anemia (<10 g %) in 39 (57.3%) cases, high erythrocyte 
sedimentation rate (ESR) (>50 mm at the end of one hour) 
(55, 80.8%), leucocytosis (>11 000/cumm) (10, 14.7%), 
leucopenia (<4 000/cumm) (10, 14.7%),  thrombocytopenia 
(<1.5 lakh/cumm) (23, 33.82%) and thrombocytosis(>4l 
akhs/cumm) in 2(2.94%) cases. Brucellosis was diagnosed 
by culturing sera/body fluids on BACTEC (or) by standard 
agglutination test (SAT) for brucella agglutinins. A titer of 
1: 320 was considered as diagnostic standard of brucellosis 
which was positive in 61 (90%). Fifty (74%) had BACTEC 
blood, 2 (3%) had CSF and 3 (4%) had bone marrow 
growing brucella. Six patients (8.82%) were given empirical 
anti tuberculosis therapy  as there was a diagnostic 
dilemma and the symptoms, signs and labs simulated 
tuberculosis. The different treatment regimens employed 
in our patients included a combination of doxycycline 
and rifampicin in 3 (4%) cases or doxycycline, rifampicin 
and aminoglycoside (streptomycin/gentamicin) in 17(25%) 
cases or doxycycline and aminoglycoside in 48(71%) cases. 
Complications included endocarditis (2, 3%), orchitis (2, 
3%), neurobrucellosis (3, 4%), and death (1, 1.47%).
  There was a patient presenting with chronic meningo 
encephalitis with hydrocephalus masquerading as tubercular 
meningitis who improved with therapy. A 30 year old lady 
presenting with spinal epidural abscess with vertebral 
osteomyelitis according to magnetic resonance imaging 
(MRI) (Figure 1). A 45 year old lady in this study had 
endocarditis with vegetation on the right coronary cusp of 
the bicuspid aortic valve and responded to medical therapy 
(Figure 2).
 
Figure 1.  MRI in a 30 year old female showing spinal epidural 
abscess with vertebral osteomyelitis (A:T1W sagittal , B: post 
contrast). 
Section of cervical spine showing an epidural abscess (濛) compressing 
the spinal cord at C6-C7 level with associated hypointensity of the 
involved vertebra suggestive of spondylodiskitis.
 
Figure 2. Echocardiographic photograph revealing vegetation on the 
right coronary cusp of the bicuspid aortic valve.
4. Discussion
  Brucellosis is caused by the facultative gram negative 
bacteria belonging to the genus Brucella. Brucellosis is the 
commonest anthropozoonotic infection with a pandemic 
distribution[1] and remains an uncontrolled problem in 
regions of high endemicity such as Mediterranean, Middle 
East, Africa, Latin America and parts of Asia. It has 
earned its name as a great imitator alongside tuberculosis 
and syphilis as it mimics multiple infectious and non 
infectious pathologies. Human infection can occur through 
consumption of unpasteurised dairy products and raw 
meat which may contain the bacteria. Infection can also 
occur through skin abrasions and inhalation of airborne 
animal manure. Occupational exposure of veterinarians 
and laboratory personnel can result in transmission of the 
disease through contaminated aerosols[5, 6]. The disease 
can present as an acute febrile illness but also has a 
tendency towards chronicity and persistence, becoming a 
granulomatous disease capable of affecting any organ system [7].
The timely and accurate diagnosis of human brucellosis 
continues to challenge clinicians because of its non-specific 
clinical features, slow growth rate in blood cultures, and the 
complexity of its serodiagnosis [8]. 
  Most of our  patients in this study were agriculturists and 
from a rural base which has also been cited in other studies 
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by Mantur et al.[6,9] Human brucellosis affects all age groups 
and our study also revealed a wide range of age distribution 
between 9 and 75 years.  The mean age with brucellosis 
in our study was 40 years as has been described in other 
studies [10].
  This reflects the magnitude of the socio-economic impact 
of brucellosis in endemic areas like India, as it affects 
mainly the most productive group in the population. Male 
preponderance 46 (68%) in our study is probably because 
of constant close contact with livestock during outdoor 
agricultural activities and milking the cows. This observation 
has also been seen in studies by Kochar et al in Bikaner[9]. 
Forty four (64.7%) gave history of contact with infected 
animals or ingestion of unpasteurised dairy products which 
may have resulted in the transmission of the disease [6,10].
  14 % of the patients presented with fever < 1 week, 23% 
with fever of 1-4 weeks and 63% with fever of > 4 weeks. 
This suggests that more than 50% had a chronic presenting 
complaint which was also seen in other comparative studies 
in India and worldwide [9,12].
  The commonest presenting symptoms include fever (68, 
100%), myalgia (21, 31%), musculoskeletal symptoms 
(arthralgia, backache) (23, 34%), headache (16, 24%), 
gastrointestinal symptoms (nausea, vomiting, diarrhoea, 
constipation and pain abdomen) (19, 28%) and altered 
sensorium in 3 (4%). In a study by Kokoglu et al,[12] out 
of 138 patients, 108 (78.3%) had fever, 107(77.5%) had 
arthralgia and 98 (71%) presented with constitutional 
symptoms. Mantur et al[6], in 2006 studied 495 patients and 
417 (84.2%) had fever, 117(23.6%) had arthralgia and 6 (1.2%) 
had constitutional symptoms. In our study, 4 (6%) had 
splenic enlargement, 6 (7%) had hepatomegaly and 19 (28%) 
had hepatosplenomegaly. 37 (26.8%) had hepatomegaly 
and 50 (36.2%) splenomegaly in a study done by Kokoglu et 
al.[12]. There have been no reported studies in India to the 
best of our knowledge which have highlighted the laboratory 
parameters, especially the haematological profile. 
  In our study, anaemia was present in 39 (57.3%) cases, 
leuopenia in 10(14.7%), leucocytosis in 10 (14.7%), 
thrombocytopenia in 23 (33.82%), thrombocytosis in 2 
(2.94%) and elevated ESR in  55 (80.8%). A higher proportion 
of our patients had anemia. This could be due to the 
chronicity of infection in 63% of the patients and rural base 
with low socio economic status (concomitant nutritional 
anemia and iron deficiency due to hook worm infestation). 
In Hasanjani Roushan et al[13] study on 469 patients, 71 
(15.1%) had anemia, 14 (3.0%) had leucopenia, 57 (12.2%) 
had leucocytosis, 16 (3.4%) had thrombocytopenia, 5 (1.1%) 
had thrombocytosis and 365 (77.8%) showed elevated ESR.
  The associated illnesses included HIV in 2 cases (3%). 
The association of brucellosis with HIV had been reported 
in case reports earlier. The clinical presentation, diagnosis, 
response to therapy and outcome are similar to those 
observed in non-HIV infected patients [14].
  In addition, other immunocompromised states like type 
2 Diabetes mellitus (13, 19%), steroid therapy (3, 4%) and 
HBsAg positivity in 8 cases (12%) were observed in our 
study [15].
  Brucellosis was diagnosed in our study by culturing sera/
body fluids on BACTEC[16] or by standard agglutination 
test (SAT) for brucella agglutinins. A titer of 1: 320 was 
considered diagnostic of brucellosis[4]. Several studies 
have shown that blood culture is the gold standard in the 
diagnosis of brucellosis.  The conventional method for 
the isolation of Brucella spp. from clinical specimens has 
been replaced by automated culture systems—which has a 
higher sensitivity and aids in early diagnosis[17,18]. The  lysis 
centrifugation can have a sensitivity of 90% in acute and 
70% in chronic cases. Our study also showed a sensitivity of 
80.8% for isolation of Brucella spp. by BACTEC method [18, 
19].
  Bone marrow cultures may provide a higher sensitivity, 
yield faster culture times, and may be superior to blood 
cultures when evaluating patients with prior antibiotic use [20].
  Brucella can also be cultured from body fluids such as CSF 
as seen in our study where 2 (3%) and 3 (4%) cases were 
isolated from CSF and bone marrow [20].
  When culture facilities are unavailable, the diagnosis of 
brucellosis depends on the serum agglutination test. In 
endemic areas, high background values could occur that 
may affect the diagnostic value of the test [4].  Hence we 
considered a higher cut off of 1: 320 for the diagnosis [6]. 
The specificity and positive predictive value of a positive 
test result could be increased by selecting a higher cut-off 
value for areas where brucellosis is endemic.  Mantecon et 
al [4] in their study showed a sensitivity of 84.6% on standard 
agglutination test at any titer in patients with culture proven 
brucellosis as compared to 86% in the our study [21].
  Complications in our study included neurobrucellosis 
(3, 4%), endocarditis (2, 3%), orchitis (2, 3%), and 
death (2, 3%). In a study done by Kochar et al [9], out 
of 175 cases, 1 had endocarditis, 33 neurobrucellosis 
and 5 orchitis. Neurological complications can include 
peripheral neuropathies, chorea, meningoencephalitis, 
transient ischemic attacks, psychiatric manifestations, 
and cranial nerve palsy. In a series of 305 patients with 
brucellosis from Turkey, 20 (6.6%) patients presented 
with neurological involvement compared to 3 (4%) in our 
study [22]. We reported a patient presenting with chronic 
meningo encephalitis with hydrocephalus masquerading 
as tubercular meningitis who improved with therapy. First 
case of neurobrucellosis associated with hydrocephalus 
was described by Gunney et al in 2008 after consumption 
of fresh sheep cheese, stressing the need to consider neuro 
brucellosis in any case of hydrocephalus, especially in 
endemic areas of brucellosis with hydrocephalus [23,24].
  A 30 year old lady presenting with spinal epidural abscess 
with vertebral osteomyelitis which has been reported as 
a rare complication seen in 0.1% of brucellosis cases was 
observed in this study. Magnetic resonance imaging (MRI) 
has become a powerful aid in investigating bone and soft 
tissue lesions in brucellosis [25]. 
  The incidence of cardiovascular complications in 
brucellosis, such as endocarditis, myocarditis or 
pericarditis, is reported to be as low of 1% of cases [26]. 
In cases of endocarditis, which is the most common 
cardiovascular involvement of the disease, the aortic valve 
and less frequently the mitral valve are affected. No good 
response to medical therapy has been observed, and there 
is poor prognosis without surgery [26-28]. A 45 year old lady 
in our study had endocarditis with vegetation on the right 
coronary cusp of the bicuspid aortic valve and responded 
to medical therapy [29]. In our study, 2 (3%) patients had 
epididymoorchitis which has also been seen with a similar 
incidence in the study done by Kochar et al in Bikaner, 
India [9].  One of our patients succumbed to the illness and it 
was a case of fatal myocarditis [30]. 
  WHO issued recommendations for the treatment of human 
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brucellosis in 1986, suggesting the use of doxycycline, 
100 mg twice daily for six weeks combined with either 
rifampicin, 600-900 mg daily for six weeks, or streptomycin, 
1 g daily for 2-3 weeks. The Ioannina recommendations 
were developed in November 2006 and this included 
gentamicin as an alternative to streptomycin in combination 
with doxycycline. It also included suphamethoxazole-
trmethoprim (TMP-SMX) and quilone regimens [31,32].  We 
followed the WHO and Ioannina recommendations and there 
was no relapse or failure with the use of these guidelines.
  Six (8.82%) of our patients received empirical anti 
tuberculosis therapy as the clinical presentation and labs 
revealed a diagnostic dilemma [3, 9, 23]. Since the two infections 
have a significant overlap in therapy, accurate diagnosis is the 
need of the hour to prevent resistance to rifampicin.
  Brucellosis is a neglected tropical disease with unusual 
clinical manifestations requiring timely and accurate 
diagnosis to prevent morbidity and mortality.
  In countries like India, where brucellosis and tuberculosis 
are common, there is urgent need to develop rapid, reliable, 
highly sensitive and easy to perform automated systems 
to detect brucella species to prevent streptomycin and 
rifampicin resistance (in view of treatment overlap). We 
found an association of brucellosis and hepatitis B in this 
study. Hence further studies are required to correlate this 
relationship. Though India is endemic for brucellosis, 
further studies are required to know the true incidence in 
the population. Routine serological testing for brucellosis 
in patients with prolonged febrile illness is required in 
endemic countries. Prevention depends on control of disease 
in animal hosts, effective heat treatment of dairy products, 
hygienic precautions and effective vaccines. 
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